Endra Life Sciences Inc Expected To Post A Loss Of 90 Cents A Share: Earnings Preview

ENDRA Life Sciences

11/03/2023 24:31

* ENDRA Life Sciences Inc  NDRA.OQ   NDRA.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 14. 
    * The Ann Arbor Michigan-based  company is expected to
report
revenue of $700 thousand, according to the mean estimate from 2
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for ENDRA Life Sciences
Inc
is for a loss of 90 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ENDRA Life
Sciences Inc is $92.5​, above​ its last closing price of $3.60.
​​​

This summary was machine generated March 11 at 00:31 GMT.  All
figures in US dollars  unless otherwise stated